Related Experiment Video
Updated: May 18, 2026
07:16
Thermal Ablation for the Treatment of Abdominal Tumors
Published on: March 7, 2011
Thyroid nodules treated with percutaneous radiofrequency thermal ablation: a comparative study
A Faggiano1, V Ramundo, A P Assanti
1Department of Molecular and Clinical Endocrinology and Oncology, Federico II University of Naples, Via Sergio Pansini 5, 80131 Naples, Italy. afaggian@unina.it
The Journal of Clinical Endocrinology and Metabolism
|September 29, 2012
Summary
Radiofrequency thermal ablation (RTA) significantly reduced thyroid nodule (TN) volume and improved symptoms. This effective treatment offers a valid alternative for patients with TNs unresponsive to conventional therapies.
Area of Science:
- Endocrinology
- Minimally Invasive Procedures
- Oncology
Background:
- Thyroid nodules (TNs) are common, and compressive TNs can cause discomfort.
- Radiofrequency thermal ablation (RTA) is an emerging treatment for TNs.
- The efficacy of RTA compared to no treatment needs further investigation.
Purpose of the Study:
- To evaluate the effectiveness of percutaneous RTA in managing thyroid nodules.
- To compare RTA outcomes against a matched, untreated control group.
Main Methods:
- Forty patients with compressive TNs (22 nontoxic, 18 toxic) were included.
- Twenty patients underwent RTA (Group A), and 20 served as controls (Group B).
- Patients were assessed clinically, biochemically, and morphologically at baseline and up to 12 months post-treatment.
Main Results:
- RTA significantly reduced TN volume (1.8 ml vs. 13.3 ml at 12 months, P < 0.0001).
- Pressure symptoms improved in all RTA-treated patients.
- Hyperthyroidism resolved or improved in 80% of toxic TN patients treated with RTA.
Conclusions:
- RTA effectively reduces thyroid nodule volume and alleviates associated pressure symptoms.
- RTA demonstrates significant benefits for hyperthyroidism in patients with toxic TNs.
- RTA is a safe and viable therapeutic option for TN management.
